Overview

Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds

Status:
Completed
Trial end date:
2018-11-03
Target enrollment:
Participant gender:
Summary
Open-label, randomized, microdose study
Phase:
Early Phase 1
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command
Collaborator:
Walter Reed Army Institute of Research (WRAIR)